Study of Efficacy of Phenytoin in Therapy of Children With Bronchial Asthma

NCT00366067 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2009-02-19

No results posted yet for this study

Summary

The purpose of this study was to determine whether antiepileptic drug phenytoin is effective in the treatment of chronic asthma in children.

Conditions

  • Bronchial Asthma

Interventions

DRUG

Phenytoin

Sponsors & Collaborators

  • Rea Rehabilitation Centre, Georgia

    collaborator OTHER
  • Centre of Chinese Medicine, Georgia

    lead OTHER

Principal Investigators

  • Merab Lomia, MD, PhD · "Rea" Rehabilitation Centre

  • Tamuna Tchelidze · CRO Evidence

  • Nana Zhorzholadze, MD · "Rea" Rehabilitation Centre

  • Manana Pruidze · Centre of Chinese Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
4 Years
Max Age
14 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-08-31
Completion
2007-02-28

Countries

  • Georgia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00366067 on ClinicalTrials.gov